neoadjuvant therapy for mibc in the genomic era
Published 1 year ago • 489 plays • Length 16:42Download video MP4
Download video MP3
Similar videos
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
19:21
immunotherapy for muscle invasive bladder cancer
-
8:08
neoadjuvant therapy for localized upper tract urothelial carcinoma
-
15:22
neoadjuvant immune checkpoint inhibition for muscle invasive bladder cancer
-
5:25
neoadjuvant cisplatin-based chemotherapy for muscle invasive bladder cancer
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
22:25
neoadjuvant vs. adjuvant vs. none – “perioperative therapy”
-
17:58
state of the art - neoadjuvant chemotherapy becoming standard of care in mibc?
-
8:19
neoadjuvant chemotherapy prior to cystectomy con argument
-
10:15
point-counterpoint: neoadjuvant chemotherapy prior to cystectomy - con
-
9:13
neoadjuvant chemotherapy prior to cystectomy pro argument
-
4:08
hcrn gu 16-257: neoadjuvant therapy for patients with mibc
-
11:52
point-counterpoint: neoadjuvant chemotherapy prior to cystectomy (pro)
-
21:10
prioritizing the optimal therapy for t1 bladder cancer: using the old and new
-
25:18
are we ready to accept neoadjuvant as the gold standard
-
17:06
muscle invasive bladder cancer guidelines review
-
43:17
case-based panel discussion: muscle-invasive bladder cancer
-
14:13
point-counterpoint: muscle invasive bladder cancer–trimodal therapy perspective
-
22:21
muscle invasive bladder cancer 2018 guidelines